'Data exclusivity' diaporamas de présentation

Data exclusivity, patents and registration of medicines

Data exclusivity, patents and registration of medicines. Karin Timmermans. TWN Regional Workshop Kuala Lumpur on bilateral trade agreements Aug. 2005. I. Data exclusivity - what is it, and what are its implications? - does TRIPS require it?

829 views • 53 slides

Data exclusivity, patents and registration of medicines

Data exclusivity, patents and registration of medicines. Karin Timmermans. TWN Regional Workshop Kuala Lumpur on bilateral trade agreements Aug. 2005. I. Data exclusivity - what is it, and what are its implications? - does TRIPS require it?

757 views • 53 slides

Treatment + research activism in India Challenges and opportunities

Treatment + research activism in India Challenges and opportunities. UAEM conference John Hopkins University 30 th October 2011. Brief history. What is a patent?. Patent. No patent. One producer. Multiple producers. No competition. Competition. High prices of imported medicines.

507 views • 37 slides

Intellectual Property Rights and Access to Medicines: The Struggle for HIV/AIDS Drugs in Thailand

Intellectual Property Rights and Access to Medicines: The Struggle for HIV/AIDS Drugs in Thailand . Noah Metheny, Esq. Thai AIDS Treatment Action Group (TTAG) Chiang Mai University, Faculty of Law February 2, 2011. Introduction to Intellectual Property Law. General IP Law

584 views • 36 slides

Brussels 21-22 September 2008

458 views • 29 slides

TPP: Are Data Exclusivity Provisions Reasonable?

396 views • 25 slides

VISION: 10/03

Growth Perspective of Indian Pharmaceutical Industry. by D G Shah Secretary General Indian Pharmaceutical Alliance. New Delhi October 30, 2003. 1. VISION: 10/03. Patents & Implications for the Indian Pharmaceutical Sector. Outline of Presentation. Introduction

427 views • 25 slides

TRIPS-Plus Provisions in EU FTAs Impact on Public Health and Access to Medicines

TRIPS-Plus Provisions in EU FTAs Impact on Public Health and Access to Medicines. Mohammed El Said (UCLAN) IP and Access to Medicines UNDP, Kiev 22-23 June 2010. Overview. EU and IP protection EU and bilateral trade agreements Some TRIPS-Plus provisions under EU bilateral trade agreements.

459 views • 23 slides

Prof. Dr. M. Fethi ?ahin

474 views • 21 slides

Cristina de A. Possas Research and Technological Development Unit National STD-AIDS Program

275 views • 19 slides

TPP & BALANCED PHARMACEUTICAL PATENT SYSTEM

329 views • 19 slides

Kevin Outterson mko@bu

New Business Models for Preventing and Treating Bacterial Diseases House Energy & Commerce Committee September 19, 2014. Kevin Outterson mko@bu.edu. A Serious Problem.

261 views • 18 slides

GREG PERRY Director General, EGA World Science Forum Budapest 10-12 November 2005

Patents and Medicines: How the system has discouraged innovation and reduced patient access to benefits of knowledge. GREG PERRY Director General, EGA World Science Forum Budapest 10-12 November 2005. Medicines Applying Scientific Knowledge for Mankind.

404 views • 17 slides

An Ethical Pathway to register pharmaceutical & biological products

An Ethical Pathway to register pharmaceutical & biological products. Judit Rius Sanjuan Knowledge Ecology International. NLARx Winter meeting Washington, DC - January 21, 2011. Outline.

340 views • 15 slides

294 views • 15 slides

Momenta Pharmaceuticals, Inc.

408 views • 14 slides

Data Exclusivity in Free Trade Agreements and Access to Originator (R&D Pharma) Medicine

254 views • 14 slides

World Trade Organization (WTO) accession and implications for public health

323 views • 13 slides

Patent Law Issues in Recent FTAs

IP, FTAs, and Sustainable Development February 27, 2006. Patent Law Issues in Recent FTAs. Joshua D. Sarnoff Washington College of Law American University Washington, DC, USA jsarnoff@wcl.american.edu. Overview. Background Patent-Related Issues in Recent FTAs Data Exclusivity

213 views • 11 slides

Proposed FOB Legislation Patent Provisions

Proposed FOB Legislation Patent Provisions. AIPLA Mid-Winter Conference Biotechnology Committee Donald R. Ware, Foley Hoag LLP January 24, 2008. Patent Provisions in Pending Bills. Access to Live Saving Medicines Act (Waxman Bill) HR 1038 (Waxman), S 623 (Clinton-Schumer)

132 views • 4 slides